Frazier Lifesciences Acquisition Corp - FORM S-1 - EX-23.1 - EXHIBIT 23.1 - November 20, 2020

Attached files

file filename
EX-99.3 - EXHIBIT 99.3 - Frazier Lifesciences Acquisition Corptm2033264d3_ex99-3.htm
EX-99.2 - EXHIBIT 99.2 - Frazier Lifesciences Acquisition Corptm2033264d3_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - Frazier Lifesciences Acquisition Corptm2033264d3_ex99-1.htm
EX-14 - EXHIBIT 14 - Frazier Lifesciences Acquisition Corptm2033264d3_ex14.htm
EX-10.8 - EXHIBIT 10.8 - Frazier Lifesciences Acquisition Corptm2033264d3_ex10-8.htm
EX-10.7 - EXHIBIT 10.7 - Frazier Lifesciences Acquisition Corptm2033264d3_ex10-7.htm
EX-10.6 - EXHIBIT 10.6 - Frazier Lifesciences Acquisition Corptm2033264d3_ex10-6.htm
EX-10.5 - EXHIBIT 10.5 - Frazier Lifesciences Acquisition Corptm2033264d3_ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - Frazier Lifesciences Acquisition Corptm2033264d3_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - Frazier Lifesciences Acquisition Corptm2033264d3_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - Frazier Lifesciences Acquisition Corptm2033264d3_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Frazier Lifesciences Acquisition Corptm2033264d3_ex10-1.htm
EX-5.2 - EXHIBIT 5.2 - Frazier Lifesciences Acquisition Corptm2033264d3_ex5-2.htm
EX-5.1 - EXHIBIT 5.1 - Frazier Lifesciences Acquisition Corptm2033264d3_ex5-1.htm
EX-4.4 - EXHIBIT 4.4 - Frazier Lifesciences Acquisition Corptm2033264d3_ex4-4.htm
EX-4.3 - EXHIBIT 4.3 - Frazier Lifesciences Acquisition Corptm2033264d3_ex4-3.htm
EX-4.2 - EXHIBIT 4.2 - Frazier Lifesciences Acquisition Corptm2033264d3_ex4-2.htm
EX-4.1 - EXHIBIT 4.1 - Frazier Lifesciences Acquisition Corptm2033264d3_ex4-1.htm
EX-3.2 - EXHIBIT 3.2 - Frazier Lifesciences Acquisition Corptm2033264d3_ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - Frazier Lifesciences Acquisition Corptm2033264d3_ex3-1.htm
EX-1.1 - EXHIBIT 1.1 - Frazier Lifesciences Acquisition Corptm2033264d3_ex1-1.htm
S-1 - S-1 - Frazier Lifesciences Acquisition Corptm2033264-2_s1.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the use in this Registration Statement on Form S-1, of our report dated October 15, 2020, relating to the balance sheet of Frazier Lifesciences Acquisition Corporation as of October 7, 2020, and the related statements of operations, changes in stockholder’s equity and cash flows for the period from October 7, 2020 (inception) through October 7, 2020, and to the reference to our Firm under the caption “Experts” in the Prospectus.

 

/s/ WithumSmith+Brown, PC  
   
New York, New York  
November 20, 2020